These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 11706701

  • 1. Factor VIII inhibitor with catalytic activity towards factor VIII.
    Lacroix-Desmazes S, Sooryanarayana, Moreau A, Horn MP, Kazatchkine MD, Kaveri SV.
    Chem Immunol; 2000; 77():102-14. PubMed ID: 11706701
    [No Abstract] [Full Text] [Related]

  • 2. Catalytic activity of antibodies against factor VIII in patients with hemophilia A.
    Lacroix-Desmazes S, Moreau A, Sooryanarayana, Bonnemain C, Stieltjes N, Pashov A, Sultan Y, Hoebeke J, Kazatchkine MD, Kaveri SV.
    Nat Med; 1999 Sep; 5(9):1044-7. PubMed ID: 10470082
    [Abstract] [Full Text] [Related]

  • 3. Proteolytic antibodies against factor VIII in hemophilia A.
    Stollar BD.
    N Engl J Med; 2002 Feb 28; 346(9):702-3. PubMed ID: 11870249
    [No Abstract] [Full Text] [Related]

  • 4. Catalytic antibodies to factor VIII in haemophilia A.
    Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV.
    Blood Coagul Fibrinolysis; 2003 Jun 28; 14 Suppl 1():S31-4. PubMed ID: 14567533
    [Abstract] [Full Text] [Related]

  • 5. The prevalence of proteolytic antibodies against factor VIII in hemophilia A.
    Lacroix-Desmazes S, Bayry J, Misra N, Horn MP, Villard S, Pashov A, Stieltjes N, d'Oiron R, Saint-Remy JM, Hoebeke J, Kazatchkine MD, Reinbolt J, Mohanty D, Kaveri SV.
    N Engl J Med; 2002 Feb 28; 346(9):662-7. PubMed ID: 11870243
    [Abstract] [Full Text] [Related]

  • 6. Factor VIII inhibitor with catalytic activity towards factor VIII.
    Lacroix-Desmazes S, Sooryanarayana, Moreau A, Kazatchkine MD, Kaveri SV.
    Haematologica; 2000 Oct 28; 85(10 Suppl):89-92. PubMed ID: 11187883
    [Abstract] [Full Text] [Related]

  • 7. Autoantibodies to factor VIII with catalytic activity.
    Bayry J, Lacroix-Desmazes S, Pashov A, Stahl D, Hoebeke J, Kazatchkine MD, Kaveri SV.
    Autoimmun Rev; 2003 Jan 28; 2(1):30-5. PubMed ID: 12848973
    [Abstract] [Full Text] [Related]

  • 8. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B, Mahendra A, Dimitrov JD, Friboulet A, Borel-Derlon A, Rao DN, Uda T, Borg JY, Bayry J, Kaveri SV, Lacroix-Desmazes S.
    FEBS Lett; 2009 Aug 06; 583(15):2565-72. PubMed ID: 19595998
    [Abstract] [Full Text] [Related]

  • 9. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
    Wootla B, Dasgupta S, Dimitrov JD, Bayry J, Lévesque H, Borg JY, Borel-Derlon A, Rao DN, Friboulet A, Kaveri SV, Lacroix-Desmazes S.
    J Immunol; 2008 Jun 01; 180(11):7714-20. PubMed ID: 18490775
    [Abstract] [Full Text] [Related]

  • 10. Treatment of severe bleeding in hemophilia A with factor VIII inhibitor.
    Mahasandana C, Suvatte V, Tanphaichitr VS, Bejrachandra S, Chandanayingyong D.
    J Med Assoc Thai; 1988 Mar 01; 71(3):154-8. PubMed ID: 3133440
    [No Abstract] [Full Text] [Related]

  • 11. Immunoblot cross-reactivity of factor VIII inhibitors with porcine factor VIII.
    Koshihara K, Qian J, Lollar P, Hoyer LW.
    Blood; 1995 Sep 15; 86(6):2183-90. PubMed ID: 7662967
    [Abstract] [Full Text] [Related]

  • 12. Complications of hemophilia A treatment: factor VIII inhibitors.
    Kasper CK.
    Ann N Y Acad Sci; 1991 Sep 15; 614():97-105. PubMed ID: 1902643
    [No Abstract] [Full Text] [Related]

  • 13. Anti-factor VIII antibodies (Inhibitors) in hemophilia A: in dire need of basic and therapeutic research.
    Kaveri SV.
    Clin Rev Allergy Immunol; 2009 Oct 15; 37(2):55-7. PubMed ID: 19153680
    [No Abstract] [Full Text] [Related]

  • 14. Inhibitor to factor VIII in mild haemophilia.
    Kesteven PJ, Holland LJ, Lawrie AS, Savidge GF.
    Thromb Haemost; 1984 Aug 31; 52(1):50-2. PubMed ID: 6437010
    [Abstract] [Full Text] [Related]

  • 15. Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
    Lacroix-Desmazes S, Wootla B, Dasgupta S, Delignat S, Bayry J, Reinbolt J, Hoebeke J, Saenko E, Kazatchkine MD, Friboulet A, Christophe O, Nagaraja V, Kaveri SV.
    J Immunol; 2006 Jul 15; 177(2):1355-63. PubMed ID: 16818797
    [Abstract] [Full Text] [Related]

  • 16. Immunochemical characterization of factor VIII inhibitors.
    Hoyer LW, Gawryl MS, de la Fuente B.
    Prog Clin Biol Res; 1984 Jul 15; 150():73-85. PubMed ID: 6431443
    [Abstract] [Full Text] [Related]

  • 17. In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.
    Scandella DH, Nakai H, Felch M, Mondorf W, Scharrer I, Hoyer LW, Saenko EL.
    Thromb Res; 2001 Mar 01; 101(5):377-85. PubMed ID: 11297754
    [Abstract] [Full Text] [Related]

  • 18. Antibodies with hydrolytic activity towards factor VIII in patients with hemophilia A.
    Lacroix-Desmazes S, Misra N, Bayry J, Villard S, Kazatchkine MD, Kaveri SV.
    J Immunol Methods; 2002 Nov 01; 269(1-2):251-6. PubMed ID: 12379365
    [Abstract] [Full Text] [Related]

  • 19. Adsorption of immunoglobulin G and anti-factor VIII inhibitory antibody from haemophiliac plasma to derivatized polystyrenes.
    Cornelius RM, Dahri L, Boisson-Vidal C, Muller D, Jozefonvicz J, Brash JL.
    Biomaterials; 1997 Mar 01; 18(5):429-36. PubMed ID: 9061184
    [Abstract] [Full Text] [Related]

  • 20. Factor VIII inhibitor assay using plasma F VIII versus recombinant F VIII--a comparative study.
    Hillman-Wiseman C, Vitale C, Lusher J.
    Thromb Res; 1994 Oct 15; 76(2):221-4. PubMed ID: 7863471
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.